The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes
2011

Rapamycin Reduces iNOS mRNA Stability in Astrocytes

publication Evidence: moderate

Author Information

Author(s): Lisi Lucia, Navarra Pierluigi, Feinstein Douglas L, Dello Russo Cinzia

Primary Institution: Istitute of Pharmacology, Catholic Medical School, Rome, Italy

Hypothesis

Does rapamycin influence iNOS mRNA stability in astrocytes?

Conclusion

Rapamycin controls the rate of iNOS mRNA degradation in astrocytes, suggesting potential benefits in treating inflammatory CNS conditions.

Supporting Evidence

  • Rapamycin significantly increased iNOS mRNA levels after 4 hours of incubation with pro-inflammatory stimuli.
  • After 48 hours, rapamycin reduced iNOS mRNA levels, indicating a change in mRNA stability.
  • Rapamycin did not significantly affect iNOS activity under basal conditions.

Takeaway

This study found that rapamycin can change how long iNOS mRNA lasts in brain cells, which might help treat brain inflammation.

Methodology

Primary cultures of rat cortical astrocytes were activated with pro-inflammatory stimuli and treated with rapamycin to measure effects on iNOS expression.

Limitations

The study did not explore the long-term effects of rapamycin on iNOS activity or mRNA stability beyond 48 hours.

Participant Demographics

Rat cortical astrocytes were used in the study.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1742-2094-8-1

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication